Arcus Biosciences
RCUS
RCUS
57 hedge funds and large institutions have $313M invested in Arcus Biosciences in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 27 increasing their positions, 13 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
11% less funds holding
Funds holding: 64 → 57 (-7)
64% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 11
Holders
57
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$3M | |
| 2 | +$1.58M | |
| 3 | +$1.4M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$1.38M |
| 5 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$599K |
Top Sellers
| 1 | -$3.56M | |
| 2 | -$2.46M | |
| 3 | -$1.07M | |
| 4 |
LCM
Laurion Capital Management
New York
|
-$734K |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$620K |